ABSTRACT:
To develop an environment-safe aqueous solubility enhancement method of poorly water-soluble drugs is the need of the pharmaceutical field. Because when organic solvents were used for solubility enhancement, there are many disadvantages like carcinogenicity, environment pollutant, flammable, toxicity, and cost. The hydrotropic method has been used to enhance the aqueous solubility of poorly water-soluble drugs. Dolutegravir is slightly soluble in water. To enhance aqueous solubility various hydrotropes were used and optimized the concentration of each hydrotrope. From these hydrotropes, a mixture of 10% sodium tricitrate and 10% sodium benzoate was selected because Dolutegravir was completely soluble in a mixed hydrotropic solution. Method development and analytical validation were performed. The maximum wavelength of Dolutegravir in the hydrotropic mixture was found a 268nm, and the linearity curve in the range of 5-25µg/ml. A regression coefficient was found to be 0.999. Percent label claim, accuracy (% RSD) were found 99.58%, 0.13(80%), 0.11(100%), 0.13(120%), respectively. The LOD for Dolutegravir was determined to be 0.037µg/ mL, and LOQ was found to be 0.11µg/mL.
Cite this article:
Poonam A. Borse Salunke, S.D. Barhate, Rupali S. Wagh. Environment safe Method development and Validation of Dolutegravir in Bulk and Tablet dosage form by UV-Visible spectroscopy. Asian Journal of Pharmaceutical Analysis. 2021; 11(2):139-4. doi: 10.52711/2231-5675.2021.00024
Cite(Electronic):
Poonam A. Borse Salunke, S.D. Barhate, Rupali S. Wagh. Environment safe Method development and Validation of Dolutegravir in Bulk and Tablet dosage form by UV-Visible spectroscopy. Asian Journal of Pharmaceutical Analysis. 2021; 11(2):139-4. doi: 10.52711/2231-5675.2021.00024 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2021-11-2-14
REFERENCES:
1. Kumar S, Singh P. “The pharma innovation:Various techniques for solubility enhancement: An overview”, The Pharma Innovation Journal 2016; 5(1): 23
2. Vemula V. R., Lagishetty V., Lingala S., “Solubility Enhancement Technique”, International Journal of Pharmaceutical Sciences Review and Research Volume 5, Issue 1, November – December 2010; Article-007:41
3. Pawar P. H., Dr. Khutle N. and Dalvi H., “Solubility Enhancement of Poorly Water Soluble Drug by using Various Solubility Enhancement technique”, World Journal of Pharmaceutical Research Review Article, Volume 7, Issue 7:1705
4. Kumar S., Singh P. “The pharma innovation: Various techniques for solubility enhancement: An overview”, The Pharma Innovation Journal 2016; 5(1): 23
5. Kapadiya N., Singhvi I., Mehta K., Karwani G. and Dhrubo J. S., “Hydrotropy: A Promising Tool for Solubility Enhancement: A Review”, International Journal of Drug Development and Research, April-June 2011, Vol. 3, Issue 2, ISSN 0975-9344:26
6. http://shodhganga.inflibnet.ac.in/bitstream/10603/17850/8/08_chapter% 201.pdf
7. Das S. “Hydrotropic Action and Solubility of Sparingly Soluble Drug”, Indian Institute of Technology Guwahati, India, 2017:3
8. Dhinakarn M., Antony Bertie Morais and Gandhi N. N., “Enhanced Solubility and Reflection of Hydrotropy Technique in the Segregation ofm/p-Aminonitrobenzen”, Chemical Science Transactions, 2012, 1(2):261
9. Kulkarni S. J., Goswami A. K., “Research on Application of Hydrotropy: A Review”, International Journal of Science, Engineering and Technology Research (IJSETR), Volume 3, Issue 10, October 2014: 2617
10. Kumar V. S., C. Raja, C. Jayakumar “A Review on Solubility Enhancement Using Hydrotropic Phenomena International Journal of Pharmacy and Pharmaceutical Sciences Vol 6, Issue 6, 2014:4
11. Khaleel N. and Rahaman S. A.,“A Validation Stability Indicating RP-HPLC Method for Simultaneous Determination of Abacavir, Lamuvidine and Dolutegravir In Bulk And Pharmaceutical Dosage”, Form World Journal of Pharmaceutical Research, Volume 4, Issue 7, 1453-1476, 17 June 2015: 1453-1476
12. Bhavar G. B., Aher K.B., Thorat R.S., Kakad S. J., Pekamwar S. S., “Development and Validation of UV Specrophotometric Method For Estimation of Dolutegravir Sodium In Tablet Dosage Form”, Malaysian Journal of Analytical Sciences, Vol 19 No 6 (2015): 1156 - 1163